This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ONLINE REGISTRATION CLOSES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Robert de Jong
Director Antibody Research & Technology at Genmab

Profile

Dr. Rob de Jong has worked in different roles at Genmab since 2007, spanning a.o. molecular biology, CMC-supportive research, and protein engineering and is an inventor of Genmab’s HexaBody® and HexElect® technologies. He currently leads Genmab’s Antibody Format Development efforts, aimed at translating biomolecular and structural insights into novel therapeutic antibody platform technologies.

Agenda Sessions

  • Co-Chairs’ Remarks

    8:10am
  • Therapeutic IgG Antibody Combinations Designed to Collaborate

    11:00am